HIV & AIDS
Stakeholders’ Experiences in Implementation of Rapid Changes to the South African Prevention of Mother-to-Child Transmission Programme
South Africa’s prevention of mother-to-child transmission (PMTCT) of the
human immunodeficiency virus (HIV) programme has undergone rapid changes in the last
two decades. Initially, the provision of single antiretroviral therapy was based on eligibility
criteria in the year 2001, which later changed to combination therapy. This was aimed at
preventing mother-to-child transmission of HIV. Since 2015, all pregnant women were eligible
for antiretroviral treatment regardless of their CD4 count. Although significant strides were
made to reduce mother-to-child transmission of HIV, increased efforts are required to meet
UNAIDS targets, World Health Organization (WHO) elimination framework goals and
sustainable development goals to eliminate new HIV infections in children and ending the
HIV epidemic by 2030.
No Related Publications available